CASI Pharma (CASI) Reports Q3 Loss of $0.05

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.05), versus ($0.07) reported last year.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Piper Sandler lists 5 chip stocks to buy
• JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
• Oppenheimer Starts Aehr Test Systems (AEHR) at Outperform, 'AI Burn-In Inflection Underappreciated'